childhood acute megakaryocytic leukemia (M7)

Search with Google Search with Bing
Information
Disease name
childhood acute megakaryocytic leukemia (M7)
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00002798 Completed Phase 3 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome August 1996
NCT00006363 Completed Phase 3 Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia November 2000
NCT01427881 Completed Phase 2 Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies September 2011 July 2015
NCT01642069 Completed Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia July 2012 May 2016
NCT00369317 Completed Phase 3 Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes March 2007 December 31, 2021
NCT00666588 Completed Phase 2 Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia April 2008 December 2012
NCT01076569 Completed Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia March 2010 May 2016
NCT01093586 Completed Phase 2 Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies September 2007 December 2015
NCT01146210 Completed Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia May 2009 May 2016
NCT01177371 Completed Phase 2 High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma March 1988 February 2010
NCT00096148 Terminated Phase 2 Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia October 2004
NCT01801046 Terminated Phase 1 Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia March 6, 2013 August 20, 2017